Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Guy

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2015
Consequences of zygote injection and germline transfer of mutant human mitochondrial DNA in miceHong Yu, Rajeshwari D Koilkonda, Tsung-Han Chou, et al.
JAMA Ophthalmology|January 25, 2014
Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trialRajeshwari D Koilkonda, Hong Yu, Tsung-Han Chou, et al.
Frontiers in Public Health|April 30, 2026
A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceAnthony L Back, Bonnie A McGregor, Leslie L Thorn, et al.
Investigative Ophthalmology & Visual Science|October 25, 2014
LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profileRajeshwari Koilkonda, Hong Yu, Venu Talla, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2015
Consequences of zygote injection and germline transfer of mutant human mitochondrial DNA in miceHong Yu, Rajeshwari D Koilkonda, Tsung-Han Chou, et al.
JAMA Ophthalmology|January 25, 2014
Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trialRajeshwari D Koilkonda, Hong Yu, Tsung-Han Chou, et al.
Frontiers in Public Health|April 30, 2026
A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceAnthony L Back, Bonnie A McGregor, Leslie L Thorn, et al.
Investigative Ophthalmology & Visual Science|October 25, 2014
LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profileRajeshwari Koilkonda, Hong Yu, Venu Talla, et al.
Pageof 7